1	Altered	alter	_	_	_	_	_	_	_
2	memory	memory	_	_	_	_	_	_	_
3	T	t	_	_	_	_	_	_	_
4	cell	cell	_	_	_	_	_	_	_
5	differentiation	differentiation	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	patients	patient	_	_	_	_	_	_	_
8	with	with	_	_	_	_	_	_	_
9	early	early	_	_	_	_	_	_	_
10	rheumatoid	rheumatoid	_	_	_	_	_	_	_
11	arthritis	arthritis	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	chronic	chronic	_	_	_	_	_	_	_
3	immune	immune	_	_	_	_	_	_	_
4	response	response	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	rheumatoid	rheumatoid	_	_	_	_	_	_	_
7	arthritis	arthritis	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	RA	RA	_	_	_	_	_	_	_
10	)	)	_	_	_	_	_	_	_
11	might	might	_	_	_	_	_	_	_
12	be	be	_	_	_	_	_	_	_
13	driven	drive	_	_	_	_	_	_	_
14	by	by	_	_	_	_	_	_	_
15	activated	activate	_	_	_	_	_	_	_
16	Th1	th1	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	without	without	_	_	_	_	_	_	_
19	sufficient	sufficient	_	_	_	_	_	_	_
20	Th2	th2	_	_	_	_	_	_	_
21	cell	cell	_	_	_	_	_	_	_
22	differentiation	differentiation	_	_	_	_	_	_	_
23	to	to	_	_	_	_	_	_	_
24	down-modulate	down-modulate	_	_	_	_	_	_	_
25	inflammation	inflammation	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	To	to	_	_	_	_	_	_	_
2	test	test	_	_	_	_	_	_	_
3	whether	whether	_	_	_	_	_	_	_
4	disordered	disorder	_	_	_	_	_	_	_
5	memory	memory	_	_	_	_	_	_	_
6	T	t	_	_	_	_	_	_	_
7	cell	cell	_	_	_	_	_	_	_
8	differentiation	differentiation	_	_	_	_	_	_	_
9	contributes	contribute	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	typical	typical	_	_	_	_	_	_	_
13	Th1-dominated	th1-dominated	_	_	_	_	_	_	_
14	chronic	chronic	_	_	_	_	_	_	_
15	inflammation	inflammation	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	RA	RA	_	_	_	_	_	_	_
18	we	we	_	_	_	_	_	_	_
19	investigated	investigate	_	_	_	_	_	_	_
20	differentiation	differentiation	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	resting	rest	_	_	_	_	_	_	_
23	CD4+	cd4+	_	_	_	_	_	_	_
24	memory	memory	_	_	_	_	_	_	_
25	T	t	_	_	_	_	_	_	_
26	cells	cell	_	_	_	_	_	_	_
27	in	in	_	_	_	_	_	_	_
28	patients	patient	_	_	_	_	_	_	_
29	with	with	_	_	_	_	_	_	_
30	early	early	_	_	_	_	_	_	_
31	(	(	_	_	_	_	_	_	_
32	6	6	_	_	_	_	_	_	_
33	wk	wk	_	_	_	_	_	_	_
34	to	to	_	_	_	_	_	_	_
35	12	12	_	_	_	_	_	_	_
36	mo	mo	_	_	_	_	_	_	_
37	)	)	_	_	_	_	_	_	_
38	untreated	untreated	_	_	_	_	_	_	_
39	RA	RA	_	_	_	_	_	_	_
40	and	and	_	_	_	_	_	_	_
41	in	in	_	_	_	_	_	_	_
42	age-	age-	_	_	_	_	_	_	_
43	and	and	_	_	_	_	_	_	_
44	sex-matched	sex-matched	_	_	_	_	_	_	_
45	healthy	healthy	_	_	_	_	_	_	_
46	controls	control	_	_	_	_	_	_	_
47	in	in	_	_	_	_	_	_	_
48	vitro	vitro	_	_	_	_	_	_	_
49	.	.	_	_	_	_	_	_	_

1	No	no	_	_	_	_	_	_	_
2	difference	difference	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	cytokine	cytokine	_	_	_	_	_	_	_
5	secretion	secretion	_	_	_	_	_	_	_
6	profiles	profile	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	freshly	freshly	_	_	_	_	_	_	_
9	isolated	isolate	_	_	_	_	_	_	_
10	memory	memory	_	_	_	_	_	_	_
11	T	t	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	was	be	_	_	_	_	_	_	_
14	detected	detect	_	_	_	_	_	_	_
15	between	between	_	_	_	_	_	_	_
16	patients	patient	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	controls	control	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	cell	cell	_	_	_	_	_	_	_
3	culture	culture	_	_	_	_	_	_	_
4	system	system	_	_	_	_	_	_	_
5	was	be	_	_	_	_	_	_	_
6	then	then	_	_	_	_	_	_	_
7	employed	employ	_	_	_	_	_	_	_
8	that	that	_	_	_	_	_	_	_
9	permitted	permit	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	differentiation	differentiation	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	Th	th	_	_	_	_	_	_	_
14	effectors	effector	_	_	_	_	_	_	_
15	from	from	_	_	_	_	_	_	_
16	resting	rest	_	_	_	_	_	_	_
17	memory	memory	_	_	_	_	_	_	_
18	T	t	_	_	_	_	_	_	_
19	cells	cell	_	_	_	_	_	_	_
20	by	by	_	_	_	_	_	_	_
21	short	short	_	_	_	_	_	_	_
22	term	term	_	_	_	_	_	_	_
23	priming	priming	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	Marked	marked	_	_	_	_	_	_	_
2	differences	difference	_	_	_	_	_	_	_
3	were	be	_	_	_	_	_	_	_
4	found	find	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	response	response	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	priming	priming	_	_	_	_	_	_	_
9	.	.	_	_	_	_	_	_	_

1	Th2	th2	_	_	_	_	_	_	_
2	cells	cell	_	_	_	_	_	_	_
3	could	could	_	_	_	_	_	_	_
4	be	be	_	_	_	_	_	_	_
5	induced	induce	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	all	all	_	_	_	_	_	_	_
8	healthy	healthy	_	_	_	_	_	_	_
9	controls	control	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	priming	prim	_	_	_	_	_	_	_
12	with	with	_	_	_	_	_	_	_
13	anti-CD28	anti-cd28	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	absence	absence	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	TCR	TCR	_	_	_	_	_	_	_
19	ligation	ligation	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	By	by	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	priming	prim	_	_	_	_	_	_	_
5	under	under	_	_	_	_	_	_	_
6	those	those	_	_	_	_	_	_	_
7	conditions	condition	_	_	_	_	_	_	_
8	resulted	result	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	Th2	th2	_	_	_	_	_	_	_
11	differentiation	differentiation	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	only	only	_	_	_	_	_	_	_
14	9	9	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	24	24	_	_	_	_	_	_	_
17	RA	RA	_	_	_	_	_	_	_
18	patients	patient	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	Exogenous	exogenous	_	_	_	_	_	_	_
2	IL-4	il-4	_	_	_	_	_	_	_
3	could	could	_	_	_	_	_	_	_
4	overcome	overcome	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	apparent	apparent	_	_	_	_	_	_	_
7	Th2	th2	_	_	_	_	_	_	_
8	differentiation	differentiation	_	_	_	_	_	_	_
9	defect	defect	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	seven	seven	_	_	_	_	_	_	_
12	patients	patient	_	_	_	_	_	_	_
13	but	but	_	_	_	_	_	_	_
14	was	be	_	_	_	_	_	_	_
15	without	without	_	_	_	_	_	_	_
16	effect	effect	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	remaining	remain	_	_	_	_	_	_	_
20	eight	eight	_	_	_	_	_	_	_
21	patients	patient	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	all	all	_	_	_	_	_	_	_
3	patients	patient	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	marked	marked	_	_	_	_	_	_	_
6	decrease	decrease	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	IL-2-producing	il-2-producing	_	_	_	_	_	_	_
9	cells	cell	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	a	a	_	_	_	_	_	_	_
12	significant	significant	_	_	_	_	_	_	_
13	increase	increase	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	well-differentiated	well-differentiated	_	_	_	_	_	_	_
16	Th1	th1	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	that	that	_	_	_	_	_	_	_
19	produced	produce	_	_	_	_	_	_	_
20	IFN-gamma	IFN-gamma	_	_	_	_	_	_	_
21	but	but	_	_	_	_	_	_	_
22	not	not	_	_	_	_	_	_	_
23	IL-2	il-2	_	_	_	_	_	_	_
24	were	be	_	_	_	_	_	_	_
25	evident	evident	_	_	_	_	_	_	_
26	after	after	_	_	_	_	_	_	_
27	priming	prim	_	_	_	_	_	_	_
28	with	with	_	_	_	_	_	_	_
29	anti-CD3	anti-cd3	_	_	_	_	_	_	_
30	and	and	_	_	_	_	_	_	_
31	anti-CD28	anti-cd28	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	data	datum	_	_	_	_	_	_	_
3	suggest	suggest	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	CD4+	cd4+	_	_	_	_	_	_	_
6	memory	memory	_	_	_	_	_	_	_
7	T	t	_	_	_	_	_	_	_
8	cells	cell	_	_	_	_	_	_	_
9	from	from	_	_	_	_	_	_	_
10	patients	patient	_	_	_	_	_	_	_
11	with	with	_	_	_	_	_	_	_
12	early	early	_	_	_	_	_	_	_
13	untreated	untreated	_	_	_	_	_	_	_
14	RA	RA	_	_	_	_	_	_	_
15	manifest	manifest	_	_	_	_	_	_	_
16	an	an	_	_	_	_	_	_	_
17	intrinsic	intrinsic	_	_	_	_	_	_	_
18	abnormality	abnormality	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	their	their	_	_	_	_	_	_	_
21	ability	ability	_	_	_	_	_	_	_
22	to	to	_	_	_	_	_	_	_
23	differentiate	differentiate	_	_	_	_	_	_	_
24	into	into	_	_	_	_	_	_	_
25	specific	specific	_	_	_	_	_	_	_
26	cytokine-producing	cytokine-producing	_	_	_	_	_	_	_
27	effector	effector	_	_	_	_	_	_	_
28	cells	cell	_	_	_	_	_	_	_
29	that	that	_	_	_	_	_	_	_
30	might	might	_	_	_	_	_	_	_
31	contribute	contribute	_	_	_	_	_	_	_
32	to	to	_	_	_	_	_	_	_
33	the	the	_	_	_	_	_	_	_
34	characteristic	characteristic	_	_	_	_	_	_	_
35	Th1-dominated	th1-dominated	_	_	_	_	_	_	_
36	chronic	chronic	_	_	_	_	_	_	_
37	(	(	_	_	_	_	_	_	_
38	auto)immune	auto)immune	_	_	_	_	_	_	_
39	inflammation	inflammation	_	_	_	_	_	_	_
40	in	in	_	_	_	_	_	_	_
41	RA	RA	_	_	_	_	_	_	_
42	.	.	_	_	_	_	_	_	_

